Cardinal Health Inc
NYSE:CAH

Watchlist Manager
Cardinal Health Inc Logo
Cardinal Health Inc
NYSE:CAH
Watchlist
Price: 239.48 USD 0.83%
Market Cap: $56.1B

Wall St Price Targets

CAH Price Targets Summary
Cardinal Health Inc

Wall Street analysts forecast CAH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAH is 252.02 USD with a low forecast of 219.4 USD and a high forecast of 288.75 USD.

Lowest Forecast
Price Target
219.4 USD
8% Downside
Average Forecast
Price Target
252.02 USD
5% Upside
Highest Forecast
Price Target
288.75 USD
21% Upside
Cardinal Health Inc Competitors:
Price Targets
JMT
JMT Network Services PCL
-14% Downside
KISS
Rojukis International PCL
-3% Downside
WRLD
World Acceptance Corp
-27% Downside
ADMR
Adaro Minerals Indonesia Tbk PT
44% Upside

Revenue
Forecast

6% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
6% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 5 years is 9%.

Gross Profit
Forecast

5% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 5 years is 9%.

Operating Income
Forecast

3% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
3% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 16%.

Pre-Tax Income
Forecast

2% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
2% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

3% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
3% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 5 years is 21%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CAH's stock price target?
Price Target
252.02 USD

According to Wall Street analysts, the average 1-year price target for CAH is 252.02 USD with a low forecast of 219.4 USD and a high forecast of 288.75 USD.

What is the Revenue forecast for Cardinal Health Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 5 years is 9%.

What is the Gross Profit forecast for Cardinal Health Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 5 years is 9%.

What is the Operating Income forecast for Cardinal Health Inc?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 16%.

What is the Pre-Tax Income forecast for Cardinal Health Inc?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Cardinal Health Inc?
Projected CAGR
21%

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 5 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett